Dronedarone restores sinus rhythm and reduces hospitalization or death in intermittent atrial fibrillation. It also lowers heart rate and blood pressure and has antiadrenergic and potential ...

Less than a year after speeding into the European Society of Cardiology's atrial fibrillation guidelines with a class 1 recommendation, the role of dronedarone (Multaq, Sanofi) in the treatment of AF ...

Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO – During the ATHENA trial, dronedarone reduced the incidence of cardiovascular hospitalizations or ...

Dronedarone is a novel antiarrhythmic drug with electrophysiological properties that are similar to those of amiodarone, but it does not contain iodine and thus does not cause iodine-related adverse ...

Two phase 3 trials of dronedarone, a novel class III antiarrhythmic agent currently in development worldwide, have demonstrated that the drug is safe and effective for the maintenance of normal sinus ...

Hammill's colleague, HRS past-president Dr Michael Cain, agreed. "We desperately would benefit from an antiarrhythmic drug that worked as well as amiodarone but had an improved safety profile." The ...

Esophageal squamous cell carcinoma (ESCC) is a severe health threat, being a predominant subtype of esophageal cancer and contributing significantly to cancer-related mortality globally. Despite ...

In a new article published in Acta Pharmaceutica Sinica B, authors Aneesh V. Karkhanis, Gopalakrishnan Venkatesan, Ryuichi Kambayashi, Atsushi Sugiyama, Eric Chun Yong Chan and colleagues from the ...

Please provide your email address to receive an email when new articles are posted on . “Despite this substantial clinical overlap and the recognition of AF as a potential therapeutic target in HF ...

Discover comprehensive details about Dronedarone, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

The Appraisal Committee reviewed the data available on the clinical and cost effectiveness of dronedarone, having considered evidence on the nature of atrial fibrillation and the value placed on the ...